CBLL vs CNMD: stock comparison and AI forecast
Ceribell, Inc. (CBLL) and Conmed Corp (CNMD) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
CBLL Ceribell, Inc.
- Market Cap
- $1.03B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
CNMD Conmed Corp
- Price
- $44.29 +20.8% · 6M
- Market Cap
- $1.33B
- P/E Ratio
- 16.4x
- Size
- small-cap
- AI Forecast
- NO CURRENT FORECAST
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- CNMD is 1.3 times larger than CBLL by market capitalization ($1.33B against $1.03B).
- CNMD turns 4.5% of its revenue into net income, against -64.7% for CBLL.
- CNMD carries 1.17 times debt per unit of equity, against 0.30 times for CBLL.
- Both companies share the SEC industry classification Electromedical & Electrotherapeutic Apparatus.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | CBLL | CNMD |
|---|---|---|
| Market Cap | $1.03B | $1.33B |
| P/E Ratio | – | 16.40x |
| P/B Ratio | 8.06x | 1.25x |
| EPS | $-1.59 | $2.70 |
| Book Value/Share | $3.34 | $35.39 |
| Revenue/Share | $2.66 | – |
| FCF/Share | $-1.43 | – |
Profitability & Margins
| Metric | CBLL | CNMD |
|---|---|---|
| ROE | -51.4% | 7.2% |
| ROA | -39.7% | 3.3% |
| ROIC | -46.9% | 8.0% |
| Gross Margin | 88.9% | 55.9% |
| Operating Margin | -68.6% | 8.6% |
| Net Margin | -64.7% | 4.5% |
| EBT Margin | -64.7% | 6.4% |
| Tax Rate | – | 30.2% |
Financial Health
| Metric | CBLL | CNMD |
|---|---|---|
| Current Ratio | 9.18x | 1.49x |
| Quick Ratio | 8.79x | 0.70x |
| D/E Ratio | 0.30x | 1.17x |
| Financial Leverage | 1.30x | 2.17x |
| Interest Coverage | -45.4x | 3.3x |
| Working Capital | $141M | $223M |
Cash Flow
| Metric | CBLL | CNMD |
|---|---|---|
| Operating Cash Flow | -$54M | $200M |
| Free Cash Flow | -$55M | – |
| Capital Spending | -$690K | – |
| OCF Growth YoY | – | 21.1% |
| FCF/Sales | -53.7% | – |
| CapEx/Sales | 0.7% | – |
Operational Efficiency
| Metric | CBLL | CNMD |
|---|---|---|
| Asset Turnover | 0.61x | – |
| Receivables Turnover | 6.4x | – |
| Inventory Turnover | 1.7x | 2.1x |
| Fixed Assets Turnover | 57.9x | – |
| Days Sales Outstanding | 57 days | – |
| Days Inventory | 217 days | 176 days |
| Payables Period | 103 days | 48 days |
| Cash Conversion Cycle | 172 days | – |
Income Statement
| Metric | CBLL | CNMD |
|---|---|---|
| Total Revenue | $102M | – |
| Operating Income | -$70M | $147M |
| Net Income | -$66M | $76M |
| R&D Expense | $23M | $76M |
| SG&A Expense | $172M | $731M |
| Cost of Goods Sold | $11M | $753M |
Dividend & Shareholder Information
| Metric | CBLL | CNMD |
|---|---|---|
| Shares Outstanding | 38M | 30M |
| Net Income Growth | – | -30.8% |
| EPS Growth | – | -32.2% |
CBLL vs CNMD: stock comparison and AI forecast
Which is bigger, CBLL or CNMD?
CNMD is 1.3 times larger than CBLL by market capitalization ($1.33B against $1.03B).
Which one does Intratio's AI model rank higher, CBLL or CNMD?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.